
|Videos|August 11, 2022
Clinical Implications of Using Genomic Testing Results in Prostate Cancer Risk-Stratification and Treatment Selection
Author(s)Stephen J. Freedland, MD
Dr Freedland discusses the clinical implications of using genomic test results for management of patients with prostate cancer.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
2
Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy
3
Urocross shows sustained benefit through 24 months post-removal
4
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
5














